Many bacterial pathogens rely on fibronectin as a surface receptor for host attachment, so competitive adhesion inhibitors based on fibronectin-binding domains derived from bacterial adhesins have large potential for future use in the management of bacterial infections. The gene discussed is FN1; the disease is bacterial infectious disease.